Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reyon Pharmaceutical Co., Ltd.

http://reyonpharm.co.kr/index.php

Latest From Reyon Pharmaceutical Co., Ltd.

The Race Is On. When Will Korea Have Its Own Approved Gene Therapy?

Scrip takes a look at the landscape of the South Korean gene and cell therapy sector, which is under the spotlight with the implementation of a new cutting-edge biologics law.

South Korea Gene Therapy

Urology: Redefining the Standards of Care

Serving the aging US demographic is a golden opportunity for urology device companies. However, at this year's meeting of the American Urological Association, the field concentrated more on consolidation of older techniques than on breakthrough technologies.

Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
  • Other Names / Subsidiaries
    • Reyon synthesis research center
    • Reyon synthesis chemicals industrial stock company corporation
UsernamePublicRestriction

Register